back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-04-04 21:53 Tx date 2024-04-01 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-3,637.29
-789 vol $4.61 each |
12,245 | |
| Filed 2024-03-28 20:43 Tx date 2024-03-28 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-3,811.50
-825 vol $4.62 each |
13,034 | |
| Filed 2024-03-28 20:42 Tx date 2024-03-27 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-3,811.50
-825 vol $4.62 each |
13,859 | |
| Filed 2024-03-28 20:38 Tx date 2024-03-26 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-3,795
-825 vol $4.60 each |
14,684 | |
| Filed 2024-03-28 20:37 Tx date 2024-03-25 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-3,951.75
-825 vol $4.79 each |
15,509 | |
| Filed 2024-03-22 17:54 Tx date 2024-03-21 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$56,830
+8,177 vol $6.95 each |
16,334 | |
| Filed 2024-03-22 17:53 Tx date 2024-03-19 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
57 - Exercise of rights
|
-8,177 vol |
30,353 | |
| Filed 2024-03-04 19:34 Tx date 2024-02-15 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$11,820
+2,000 vol $5.91 each |
8,157 | |
| Filed 2024-03-04 09:40 Tx date 2024-03-01 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$590,750
+85,000 vol $6.95 each |
734,090 | |
| Filed 2024-03-04 09:39 Tx date 2024-03-01 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
56 - Grant of rights
|
+14,000 vol |
38,530 | |
| Filed 2023-12-27 17:35 Tx date 2022-02-15 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,265
+729 vol $12.71 each |
6,157 | |
| Filed 2022-12-21 16:39 Tx date 2022-02-15 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,265
+729 vol $12.71 each |
||
| Filed 2022-02-28 20:29 Tx date 2022-02-15 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,265
+729 vol $12.71 each |
||
| Filed 2023-02-02 18:46 Tx date 2023-01-30 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
56 - Grant of rights
|
+24,530 vol |
24,530 | |
| Filed 2023-02-02 18:45 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-02-02 18:45 Tx date 2023-01-30 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,379,241
+111,050 vol $12.42 each |
649,090 | |
| Filed 2022-12-21 16:39 Tx date 2022-02-15 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,265
+729 vol $12.71 each |
6,157 | |
| Filed 2022-02-28 20:29 Tx date 2022-02-15 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,265
+729 vol $12.71 each |
||
| Filed 2022-02-28 20:29 Tx date 2022-02-15 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,265
+729 vol $12.71 each |
6,157 | |
| Filed 2022-01-20 19:06 Tx date 2022-01-18 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,563,000
+100,000 vol $15.63 each |
538,040 | |
| Filed 2021-10-06 11:12 Tx date 2021-08-13 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$12,180
+428 vol $28.46 each |
5,428 | |
| Filed 2021-04-02 13:38 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$100,000
+5,000 vol $20.00 each |
5,000 | |
| Filed 2020-07-02 20:10 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$100,000
+5,000 vol $20.00 each |
||
| Filed 2021-02-12 10:28 Tx date 2021-02-08 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,620,609
+71,000 vol $36.91 each |
438,040 | |
| Filed 2020-07-02 20:10 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$100,000
+5,000 vol $20.00 each |
5,000 | |
| Filed 2020-07-02 20:09 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-02 20:08 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
367,040 | ||
| Filed 2020-05-20 14:01 Tx date 2020-05-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Forte, Steve
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$174,400
+10,000 vol $17.44 each |
20,000 | |
| Filed 2019-11-20 11:33 Tx date 2019-11-18 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Forte, Steve
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$112,300
+10,000 vol $11.23 each |
10,000 | |
| Filed 2019-11-20 11:33 Tx date 2019-08-06 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Forte, Steve
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-04-22 10:19 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Options
59 - Exercise for cash
|
-389,100 vol |
0 | |
| Filed 2019-02-21 Tx date 2019-02-18 |
$CMTA
Clementia Pharmaceuticals Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+164,100 vol |
389,100 | |
| Filed 2018-07-16 Tx date 2018-07-12 |
$CMTA
Clementia Pharmaceuticals Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-07-16 Tx date 2018-07-12 |
$CMTA
Clementia Pharmaceuticals Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+225,000 vol |
225,000 |